Key result
This review outlines the pathophysiological mechanisms of prosthetic valve thrombosis and its clinical implications for patients undergoing transcatheter and surgical valve replacement.
Why the study?
The value of long-term anticoagulation to prevent thromboembolism after bioprosthetic heart valve replacement is uncertain, and bioprosthetic valve thrombosis presents an ongoing risk and potential cause of dysfunction.
This review summarizes data on prosthetic valve thrombosis, its pathophysiological mechanisms, and implications in the era of transcatheter valve replacement.
Answers are grounded in this paper and cite their sources.
May warrant vigilance for early thromboembolism after bioprosthetic valve implantation; leaves open long-term anticoagulation necessity.
Although surgery was the mainstay of treatment for valvular heart disease, transcatheter valve therapies have grown exponentially over the past decade. Two types of artificial heart valve exist: mechanical heart valves (MHV), which are implanted surgically, and bioprosthetic heart valves (BHV), which can be implanted via a surgical or transcatheter approach. Whereas long-term anticoagulation is required to prevent thromboembolism after MHV replacement, its value in patients receiving BHVs is uncertain. Patients undergoing transcatheter BHV replacement are at risk for thromboembolism in the first few months, and recent data suggest that the risk continues thereafter. BHV thrombosis provides a substrate for subsequent thromboembolism and may identify a reversible cause of prosthesis dysfunction. Hereafter, the authors: 1) review the data on prosthetic valve thrombosis; 2) discuss the pathophysiological mechanisms that may lead to valve thrombus formation; and 3) provide perspective on the implications of these findings in the era of transcatheter valve replacement.
No takes yet. Share an insight, caveat, or question.
Dangas et al. (2016) conducted a review in Prosthetic Heart Valve Thrombosis. Prosthetic heart valves was evaluated. This review outlines the pathophysiological mechanisms of prosthetic valve thrombosis and its clinical implications for patients undergoing transcatheter and surgical valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: